Inflammatix
Inflammatix builds host-response diagnostics that rapidly assess acute infection and sepsis in emergency care.
- 75
- Company
- Burlingame, CA, USUnited States
Inflammatix builds host-response diagnostics that rapidly assess acute infection and sepsis in emergency care.
inflammatix.comCrawled Oct 15, 2026
USA Health embraces new tool for diagnosing sepsis
The page features news and press releases about Inflammatix.
Inflammatix Collaborates with University of Nebraska Medical Center to Support Rapid Response to the Hantavirus Outbreak Using TriVerity
Inflammatix is hiring and expanding its team.
Aditya R, et al. 27th ECCMID, Vienna Austria. April 22-25, 2017.
Inflammatix is a molecular diagnostics company developing rapid tests that read the immune system to resolve major clinical and public health challenges.
Inflammatix is developing rapid point-of-care diagnostic tests by reading the immune response aimed to help physicians better diagnose acute infections and sepsis.
Inflammatix's terms of use form a legal contract with visitors and users regarding their use of the site.
LabMedica develops a rapid diagnostic test to identify sepsis patients who may benefit from corticosteroid treatment. The assay evaluates host immune response markers to guide personalized therapy decisions. Early results suggest potential for reducing trial-and-error prescribing in critical care settings.
Oct 2026Labmedica.comNews article
USA Health introduces the **TriVerity Test System**, a blood-based diagnostic tool designed to rapidly and accurately detect sepsis, a life-threatening condition. The system analyzes small blood samples to provide timely results, improving early intervention capabilities. This marks a significant advancement in sepsis diagnosis for the healthcare provider.
Jul 2026https://www.fox10tv.comNews article
AnMed becomes the first healthcare provider in South Carolina to offer the **TriVerity diagnostic test**, a rapid tool for assessing suspected infections or sepsis. The test aids clinicians in delivering targeted care more efficiently. The service expands access to advanced diagnostics in the region.
Mar 2026AnMedNews article
Stanford Medicine describes a rapid sepsis test that helps clinicians react in real time when infection in critically ill patients could otherwise be missed. The tool is intended to speed the time to treatment in cases where minutes matter most.
Feb 2026Stanford MedicineNews article